A new study from Columbia University reveals a promising RNA-based therapy that could help the heart repair itself after a heart attack. By boosting Atrial Natriuretic Peptide production, the ...
A new study shows a single RNA injection may help repair heart damage after a heart attack, reducing scarring and improving ...
A new RNA-based therapy aims to address one of cardiology’s most persistent challenges: the heart’s inability to regenerate after injury.
BACKGROUND: With the increasing diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) at earlier stages and new ...
Early and continuous treatment with acoramidis is linked to lower risks for death and heart-related hospitalization than delayed treatment in patients with transthyretin amyloid cardiomyopathy.
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for Merck’s WINREVAIR in Adults With CpcPH-HFpEF ...